These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12406838)

  • 1. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
    Goldstein I; Wallet F; Nicolas-Robin A; Ferrari F; Marquette CH; Rouby JJ
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1375-81. PubMed ID: 12406838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia.
    Elman M; Goldstein I; Marquette CH; Wallet F; Lenaour G; Rouby JJ;
    Anesthesiology; 2002 Jul; 97(1):199-206. PubMed ID: 12131123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs.
    Goldstein I; Wallet F; Robert J; Becquemin MH; Marquette CH; Rouby JJ
    Am J Respir Crit Care Med; 2002 Jan; 165(2):171-5. PubMed ID: 11790649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Girardi C; Zhang M; Bouhemad B; Louchahi K; Petitjean O; Wallet F; Becquemin MH; Le Naour G; Marquette CH; Rouby JJ
    Intensive Care Med; 2010 Jul; 36(7):1147-55. PubMed ID: 20397007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen.
    Tonnellier M; Ferrari F; Goldstein I; Sartorius A; Marquette CH; Rouby JJ
    Anesthesiology; 2005 May; 102(5):995-1000. PubMed ID: 15851887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa.
    Ferrari F; Lu Q; Girardi C; Petitjean O; Marquette CH; Wallet F; Rouby JJ;
    Intensive Care Med; 2009 Oct; 35(10):1792-800. PubMed ID: 19652947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization of Vancomycin Provides Higher Lung Tissue Concentrations than Intravenous Administration in Ventilated Female Piglets with Healthy Lungs.
    Morais CLM; Nascimento JWL; Ribeiro AC; Cortinez LI; Carmona MJC; Maia DRR; Monsel A; Auler JOC; Rouby JJ; Otsuki DA
    Anesthesiology; 2020 Jun; 132(6):1516-1527. PubMed ID: 32053565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung deposition of continuous and intermittent intravenous ceftazidime in experimental Pseudomonas aeruginosa bronchopneumonia.
    Girardi C; Tonnellier M; Goldstein I; Sartorius A; Wallet F; Rouby JJ;
    Intensive Care Med; 2006 Dec; 32(12):2042-8. PubMed ID: 16858611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of continuous positive airway pressure combined to nebulization on lung deposition measured by urinary excretion of amikacin.
    Reychler G; Leal T; Roeseler J; Thys F; Delvau N; Liistro G
    Respir Med; 2007 Oct; 101(10):2051-5. PubMed ID: 17628465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
    McClure JT; Rosin E
    Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol Route to Administer Teicoplanin in Mechanical Ventilation: In Vitro Study, Lung Deposition and Pharmacokinetic Analyses in Pigs.
    Guillon A; Mercier E; Lanotte P; Haguenoer E; Darrouzain F; Barc C; Sarradin P; Si-Tahar M; Heuzé-Vourc'h N; Diot P; Vecellio L
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):290-8. PubMed ID: 25616054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
    Li Bassi G; Motos A; Fernandez-Barat L; Aguilera Xiol E; Chiurazzi C; Senussi T; Saco MA; Fuster C; Carbonara M; Bobi J; Amaro R; De Rosa F; Comaru T; Yang H; Ranzani OT; Marti JD; Rinaudo M; Comino Trinidad O; Rigol M; Bringué J; Ramirez J; Nicolau DP; Pelosi P; Antonelli M; Blasi F; Artigas A; Montgomery AB; Torres A
    Crit Care Med; 2019 Jun; 47(6):e470-e477. PubMed ID: 30882478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Yang J; Liu Z; Gutierrez C; Aymard G; Rouby JJ;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):106-15. PubMed ID: 21474643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
    Luyt CE; Eldon MA; Stass H; Gribben D; Corkery K; Chastre J
    J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):183-90. PubMed ID: 21361783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system.
    Ghazi IM; Grupper M; Nicolau DP
    Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):2. PubMed ID: 28095918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers.
    Ferrari F; Liu ZH; Lu Q; Becquemin MH; Louchahi K; Aymard G; Marquette CH; Rouby JJ
    Intensive Care Med; 2008 Sep; 34(9):1718-23. PubMed ID: 18542922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercapnic acidosis attenuates lung injury induced by established bacterial pneumonia.
    Chonghaile MN; Higgins BD; Costello J; Laffey JG
    Anesthesiology; 2008 Nov; 109(5):837-48. PubMed ID: 18946296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
    Motos A; Yang H; Li Bassi G; Yang M; Meli A; Battaglini D; Cabrera R; Bobi J; Pagliara F; Frigola G; Camprubí-Rimblas M; Fernández-Barat L; Rigol M; Ferrer-Segarra A; Kiarostami K; Martinez D; Nicolau DP; Artigas A; Pelosi P; Vila J; Torres A
    Crit Care; 2023 Feb; 27(1):60. PubMed ID: 36788582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets.
    Guillon A; Darrouzain F; Heuzé-Vourc'h N; Petitcollin A; Barc C; Vecellio L; Cormier B; Lanotte P; Sarradin P; Dequin PF; Paintaud G; Ehrmann S
    Pulm Pharmacol Ther; 2019 Aug; 57():101807. PubMed ID: 31102741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.